Dermatology Research
Pediatric Psoriasis Study
This study is currently closed to enrollment.
Study of Risankizumab in Pediatric Patients with Moderate to Severe Plaque Psoriasis
AGE: 6-18 years old
SEX AT BIRTH: All
SEX AT BIRTH: All
TYPE: Investigational Treatment Study
CONDITION: Plaque psoriasis
CONDITION: Plaque psoriasis
HEALTHY PARTICIPANTS: No
LOCATION: University Hospitals Medical Centers
LOCATION: University Hospitals Medical Centers
Study Purpose
The purpose of this study is to evaluate Risankizumab compared to Ustekinumab for the treatment of moderate to severe plaque psoriasis who are pediatric candidates for systemic therapy.
STUDY ID#
- STUDY20210431